Drug Free Solution, Inc. (OTCPK:DSOL) announced that it has entered into a equity purchase agreement for a private placement of equity line of credit for gross proceeds of $3,000,000 with new investor Premier Venture Partners, LLC on July 14, 2014. Pursuant to the agreement, the investor shall purchase the shares over a period of 36 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% |
|
-.--% | -.--% |
2021 | Drug Free Solution, Inc. Announces Jessica Bass as CEO | CI |
2021 | Drug Free Solution, Inc. Announces Genie O'Malley as Chairwoman of the Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 88.89K | |
+25.79% | 89.18B | |
-23.21% | 76.11B | |
+2.32% | 27.11B | |
-10.58% | 17.13B | |
-0.32% | 16.83B | |
+0.52% | 15.4B | |
+77.83% | 13.68B | |
+79.56% | 13.25B | |
-25.61% | 12.83B |
- Stock Market
- Equities
- DSOL Stock
- News Drug Free Solution, Inc.
- Drug Free Solution, Inc. announced that it expects to receive $3 million in funding from Premier Venture Partners, LLC